- Containment and mitigation
- 4.3COVID-19 testing
- 4.4Research into vaccine and drug therapies
- 4.5Medical supplies
by states and territories
2020 coronavirus pandemic in the United States by state and territory | |||||||
|---|---|---|---|---|---|---|---|
| U.S. state or territory | Cases | Deaths | Recov. | Hospital | Active | Ref. | |
| 55 / 56 | 215,561 | 4,818 | 8,994 | 41,149 | 91,859 | ||
 | Alabama | 1,251 | 17 | – | – | – | [24] |
 | Alaska | 143 | 3 | 9 | 9 | – | [25] |
 | American Samoa | 0 | 0 | 0 | – | 0 | |
 | Arizona | 1,413 | 29 | – | – | 1,265 | [26] |
 | Arkansas | 643 | 12 | 47 | – | 584 | [27] |
 | California | 9,937 | 215 | 60 | 1,855 | – | [28][29] |
 | Colorado | 3,728 | 97 | – | 710 | – | [30] |
 | Connecticut | 3,557 | 85 | – | 766 | – | [31] |
 | Delaware | 368 | 11 | 49 | 51 | 308 | [32] |
 | District of Columbia | 657 | 12 | 173 | – | 468 | [33][34] |
 | Florida | 7,764 | 101 | – | 990 | – | [35] |
 | Georgia | 5,348 | 163 | – | 1,013 | – | [36] |
 | Guam | 77 | 3 | 9 | – | 65 | [37] |
 | Hawaii | 285 | 2 | 72 | 15 | 211 | [38][39] |
 | Idaho | 891 | 9 | – | 56 | – | [40] |
 | Illinois | 7,695 | 157 | – | – | – | [41] |
 | Indiana | 3,039 | 78 | – | – | – | [42] |
 | Iowa | 614 | 11 | 46 | 120 | 557 | [43][44] |
 | Kansas | 552 | 13 | – | 138 | 539 | [45] |
 | Kentucky | 770 | 31 | – | – | – | [46] |
 | Louisiana | 6,424 | 273 | – | 1,498 | – | [47] |
 | Maine | 344 | 7 | 80 | 63 | 257 | [48] |
 | Maryland | 1,985 | 31 | 69 | 522 | 1,885 | [49] |
 | Massachusetts | 8,966 | 154 | 1,655 | 813 | – | [50] |
 | Michigan | 10,791 | 417 | – | – | – | [51][52] |
 | Minnesota | 742 | 18 | 373 | 138 | 351 | [53] |
 | Mississippi | 1,073 | 22 | – | 218 | – | [54] |
 | Missouri | 1,834 | 19 | – | – | – | [55] |
 | Montana | 217 | 5 | – | 19 | – | [56] |
 | Nebraska | 214 | 4 | – | – | – | [57] |
 | Nevada | 1,279 | 32 | – | – | – | [58] |
 | New Hampshire | 415 | 4 | – | 58 | – | [59] |
 | New Jersey | 22,255 | 355 | – | 4,877 | – | [60][61] |
 | New Mexico | 403 | 7 | – | – | – | [62][63] |
 | New York | 83,948 | 1,941 | 6,142 | 18,368 | 75,865 | [23][64][65] |
 | North Carolina | 1,584 | 10 | – | 204 | – | [66] |
 | North Dakota | 159 | 3 | 43 | 28 | 113 | [67] |
 | Northern Mariana Islands | 2 | 0 | – | – | 2 | [68] |
 | Ohio | 2,547 | 65 | – | 679 | – | [69] |
 | Oklahoma | 879 | 34 | – | 257 | – | [70] |
 | Oregon | 826 | 21 | – | 188 | – | [71] |
 | Pennsylvania | 7,016 | 90 | – | 730 | – | [72] |
 | Puerto Rico | 239 | 8 | – | – | – | [73] |
 | Rhode Island | 657 | 12 | – | 72 | – | [74][75] |
 | South Carolina | 1,554 | 31 | – | 896 | – | [76] |
 | South Dakota | 165 | 2 | 57 | 17 | 106 | [77] |
 | Tennessee | 2,845 | 32 | 220 | 263 | 2,593 | [78] |
 | Texas | 4,669 | 70 | – | – | – | [79] |
 | Utah | 1,074 | 7 | – | 100 | – | [80] |
 | U.S. Virgin Islands | 37 | 0 | 29 | – | 8 | [81][82] |
 | Vermont | 338 | 17 | – | 29 | – | [83] |
 | Virginia | 1,706 | 41 | – | 246 | – | [84] |
 | Washington | 6,585 | 262 | – | 4,662 | – | [85][23] |
 | West Virginia | 217 | 2 | – | – | – | [86] |
 | Wisconsin | 1,730 | 31 | – | 461 | – | [87][88] |
 | Wyoming | 153 | 0 | 37 | 20 | 116 | [89] |
| As of 3 April 2020 (UTC) · History of cases: United States | |||||||
|
The CDC publishes official numbers every Monday, Wednesday, and Friday, reporting several categories of cases: individual travelers, people who contracted the disease from other people within the U.S., and repatriated citizens who returned to the U.S. from crisis locations, such as Wuhan, where the disease originated,
ECONOMY
COVID-19 epidemic threatens global economy
VOV.VN -
The acute respiratory illness caused by the new coronavirus (COVID-19), which in China has affected 64,000 people and caused more than 1,400 deaths, has spread to 26 countries and territories, according to the World Health Organization.
 |
| Workers manufacture products at a factory of Skyworth in Guangzhou, China, February 10, 2020 (Photo: Xinhua/VNA) |
Although statistics are still preliminary, disruptions are being reported in production and supply chains all over the world.
The COVID-19 epidemic, which broke out in early 2020 during the Lunar New Year holiday in China and several other Asian countries, has taken a toll on China’s health care, tourism, transport, trade, production value chain, and financial services.
China is racing against time to prevent the epidemic from spreading further and further destabilizing its domestic economy.
Immediate impacts
One night after China announced a new diagnostic method for confirming COVID-19, the number of deaths and infections soared and the stock markets plummeted from Asia to Wall Street.
Casinos closed in Macau. Airlines cancelled 25,000 flights to or from China and within China. 27,000 employees of Hong Kong’s Cathay Pacific were asked to take unpaid leave.
Hyundai Motor Company closed all its factories in the Republic of Korea for one week because of a lack of spare parts imported from China. Wuhan city, capital of Hubei province and the epicenter of the disease, halted all manufacturing.
From the European multinational aerospace corporation Airbus to American vehicle manufacturer Tesla and tech giant Apple, production has slowed down.
During the COVID-19 epidemic, many Chinese provinces and cities have extended the Lunar New Year holiday. These areas account for 80% of China’s GDP and produce 90% of China’s exports.
China’s shutdown of major transport arteries has wreaked havoc on the food and hospitality industries. In France, hotels suffered substantial losses as 80% of booked rooms were canceled in January and all booked rooms were cancelled in February.
Multinational companies like Google and IKEA announced temporary closure of their branches in China. The Organization of Petroleum Exporting Countries (OPEC) lowered its forecast for oil demand growth in 2020.
Russia, the Democratic People's Republic of Korea, and Mongolia closed their borders with China, while Western countries repatriated their citizens from China. Many countries warned their citizens not to travel to China. The global supply chain is disrupted because China, a link of the chain, is now ravaged by COVID-19.
Countries improve resistance to risks
Experts say it’s too early to give a full assessment of COVID-19’s impact on the world economy. But recent studies by Moody’s, BNP Paribas Cadif, and International SOS suggest that the epidemic in China, the world’s second largest economy after the US, which contributes 33% of the world’s total economic growth, will lower global GDP by 0.3-0.7% this year.
Oxford Economics forecasts that the US will experience a loss of 1.6 million visitors from mainland China this year.
Europe’s growth outlook might also be challenged because Europe has emerged as a more popular tourist destination for Chinese visitors since 2018 in the context of worsening US-China ties.
But IMF Managing Director Kristalina Georgieva on February 13 said COVID-19’s hit to global growth should be “mild.” The IMF expects a “V-shaped impact,” with a sharp decline in activity in China followed by a sharp recovery, meaning there likely will be only a mild impact on the rest of the world.
Respiratory Illness caused by the new coronavirus (COVID-19)
2020 coronavirus pandemic in the United States
| 2020 coronavirus pandemic in the United States | |
|---|---|
 Confirmed cases per million residents | |
| Disease | COVID-19 |
| Virus strain | SARS-CoV-2 |
| Location | United States |
| First outbreak | Wuhan, Hubei, China |
| Index case | Everett, Washington |
| Arrival date | January 15, 2020 (2 months, 2 weeks and 5 days ago) |
| Confirmed cases | 244,678 (JHU) 213,144 (CDC confirmed) |
| Recovered | 9,058 (JHU) |
Deaths | 5,758 (JHU) 4,513 (CDC confirmed) |
| Official website | |
| coronavirus.gov |
An ongoing worldwide pandemic of coronavirus disease 2019 (COVID-19), a new infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first confirmed to have spread to the United States in January 2020. Cases have been confirmed in all fifty U.S. states, the District of Columbia, and all inhabited U.S. territories except American Samoa. As of March 31, 2020, the U.S. has the most confirmed active cases in the world and ranks third in the number of total deaths from the virus.
The first known case of COVID-19 in the U.S. was confirmed on January 20, 2020, in a 35-year-old man who had returned from Wuhan, China, five days earlier. The White House Coronavirus Task Force was established on January 29. Two days later, the Trump administration declared a public health emergency and announced restrictions on travelers arriving from China. On February 26, the first case in the U.S. in a person with "no known exposure to the virus through travel or close contact with a known infected individual" was confirmed by the Centers for Disease Control and Prevention (CDC) in northern California.
The United States got off to a slow start in COVID-19 testing. Until the end of February, the Food and Drug Administration (FDA) procedures forbade laboratories other than the CDC from releasing test results to patients, even if they followed internationally recognized test protocols. The CDC developed and distributed test kits of its own, but many of them were found to have a manufacturing flaw in a non-essential component, which made the kit illegal to use until the protocol was changed. On February 29 the FDA began allowing public health agencies, hospitals, and private companies to develop tests and perform testing, and by mid-March private companies were shipping hundreds of thousands of tests. The FDA initially had very restrictive guidelines on who was allowed to be tested; on March 5 it said anyone with a doctor's order could be tested. As of March 25, at least 418,000 tests had been conducted, and by April 2 the number had reached 1,180,000.
The CDC warned that widespread transmission of the disease may force large numbers of people to seek hospitalization and other healthcare, which may overload healthcare systems. Since March 19, 2020, the U.S. Department of State has advised U.S. citizens to avoid all international travel. On March 16 the White House advised against any gatherings of more than 10 people. In mid-March 2020, the Federal Emergency Management Agency (FEMA) told the United States Army Corps of Engineers (USACE) to plan to construct new facilities, including leased hotels and other buildings, and to convert them for use as hospitals and intensive care units. State and local responses to the outbreak have included prohibitions and cancellation of large-scale gatherings, the closure of schools and other educational institutions, the cancellation of trade shows, conventions, and music festivals, and the cancellation and suspension of sporting events and leagues.
The COVID-19 outbreak, which the World Health Organization (WHO) declared a Public Health Emergency of International Concern by January 30, and a pandemic by March 11, has had a disparate impact on different areas of the U.S. Of the 154 known deaths in the country prior to March 20, 94 occurred in the state of Washington, with 35 of those at one nursing home.[104] By late March, the outbreak in the United States had grown the worst in New York. The state accounted for 56% of all U.S. confirmed cases on March 25, but was showing signs of a potentially declining growth rate of new cases. For the country as a whole, the mortality rate for confirmed coronavirus cases was 1.3% based on March 24 data. In comparison, the other three most effected nations had significantly higher death rates of 4% in China, 9.8% in Italy, and 7.1% in Spain, while Germany in fifth place had a lower rate of 0.5%.
In a series of travel restrictions announced between late January and mid-March, the United States government denied entry to foreign nationals who had traveled within the past 14 days through China, Iran, the United Kingdom, Ireland, or the 26 European countries that comprise the Schengen Area. Americans returning home after traveling in these regions were required to undergo a health screening and submit to a 14-day quarantine.[107][108] Such quarantines are governed by section 361 of the Public Health Service Act (42 U.S. Code § 264).[109][110] In early March, the Centers for Disease Control and Prevention (CDC) advised Americans against non-essential travel to China, Iran, Malaysia, and the aforementioned European countries.
Throughout March, several state, city, and county governments imposed "stay at home" quarantines on their populations, in order to stem the spread of the virus. By the middle of the month, all 50 states were able to perform tests, with a doctor's approval, either from the CDC or from commercial labs in a state, but the number of available test kits remained limited which meant the true number of people infected with the virus was a challenge to estimate with any reasonable accuracy at the time. The CDC suggested that doctors use their own judgment along with certain guidelines before authorizing a test. By March 12, diagnosed cases of COVID-19 in the U.S. exceeded a thousand, which doubled every two days to reach more than 17,000 by March 20.
Administration officials warned on March 19 that the number of cases would begin to rise sharply as the country's testing capacity substantially increased. Around this time, the United States began running 50,000 to 70,000 coronavirus tests per day.[ On March 26, the total number of confirmed cases surpassed that of China with over 85,000, making the U.S. the country with the highest number of coronavirus patients in the world. The country reached another critical mark, as the number of positive cases surged over 100,000 the next day on March 27.
COVID-19 testing
Beyond identifying whether a person is currently infected, coronavirus testing helps health professionals ascertain how bad the epidemic is and where it is worst. However, the accuracy of national statistics on the number of cases and deaths from the outbreak depends on knowing how many people are being tested every day, and how the available tests are being allocated. But as of late March, most countries do not provide official reports on tests performed, therefore there is no centralized WHO data on COVID-19 testing.
While the World Health Organization opted to use an approach developed by Germany to test for COVID-19, the United States developed its own testing approach. The German testing method was made public on January 13, and the American testing method was made public on January 28. The World Health Organization did not offer any test kits to the U.S. because the U.S. normally had the supplies to produce their own tests. In February, the U.S. CDC produced 160,000 coronavirus tests, but soon it was discovered that many were defective and gave inaccurate readings Although academic laboratories and hospitals had developed their own tests, they were not allowed to use them until February 29, when the FDA issued approvals for them and private companies. Approvals were required by federal law due to the outbreak being declared as a public health emergency.
Meanwhile, from the start of the outbreak to early March 2020, the CDC gave restrictive guidelines on who should be eligible for COVID-19 testing. The initial criteria were (a) people who had recently traveled to certain countries affected by the outbreak, or (b) people with respiratory illness serious enough to require hospitalization, or (c) people who have been in contact with a person confirmed to have COVID-19. Only on March 5 did the CDC relax the criteria to allow doctors discretion to decide who would be eligible for tests.
.jpg)
As a result, the United States had a slow start in conducting widespread testing for COVID-19. Fewer than 4,000 tests were conducted in the U.S. by February 27, with U.S. state laboratories conducting only around 200 The first U.S. case of a person having COVID-19 of unknown origin (a possible indication of community transmission in the state of California) saw the patient's test being delayed for four days after being hospitalized on February 19, because he had not qualified for a test under the initial federal testing criteria. Whereas in Washington state, a group of researchers defied a lack of clearance from federal and state officials to conduct their own tests from February 25, using samples already collected from their flu study that their subjects had not given permission for COVID-19 testing. They quickly found a teenager infected with COVID-19 of unknown origin, newly indicating that an outbreak was already occurring in Washington. State regulators stopped these researchers' testing on March 2.
